Seeing Is Believing
Currently out of the existing stock ratings of Keith Devas, 11 are a BUY (61.11%), 7 are a HOLD (38.89%).
Analyst Keith Devas, currently employed at JEFFERIES, carries an average stock price target met ratio of 32.78% that have a potential upside of 12.82% achieved within 43 days.
Keith Devas’s has documented 36 price targets and ratings displayed on 4 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on PRGO, Perrigo Company PLC at 07-May-2026.
Analyst best performing recommendations are on IDXX (IDEXX LABORATORIES).
The best stock recommendation documented was for KVUE (KENVUE) at 1/30/2026. The price target of $18 was fulfilled within 14 days with a profit of $1.39 (8.37%) receiving and performance score of 5.98.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 03-Nov-2014
$810
$133.96 (19.82%)
$805
9 days ago
(03-Nov-2026)
25/29 (86.21%)
$138.36 (20.60%)
363
Hold Since 01-Oct-2025
$700
$23.96 (3.54%)
$627
9 days ago
(03-Nov-2026)
6/10 (60%)
$28.36 (4.22%)
73
Buy Since 25-Jul-2024
$800
13 days ago
(30-Oct-2026)
22/25 (88%)
$167.44 (26.47%)
132
Buy Since 29-Jan-2021
$750
$73.96 (10.94%)
$775
27 days ago
(16-Oct-2026)
8/10 (80%)
$189.64 (33.84%)
446
Buy Since 09-Dec-2025
$710
$33.96 (5.02%)
$800
3 months 1 days ago
(11-Aug-2026)
0/4 (0%)
$123.36 (21.03%)
What Year was the first public recommendation made by Keith Devas?